SG96294G - 1-oxa-2-oxo-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof - Google Patents

1-oxa-2-oxo-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof

Info

Publication number
SG96294G
SG96294G SG96294A SG96294A SG96294G SG 96294 G SG96294 G SG 96294G SG 96294 A SG96294 A SG 96294A SG 96294 A SG96294 A SG 96294A SG 96294 G SG96294 G SG 96294G
Authority
SG
Singapore
Prior art keywords
group
alkyl
halogen atoms
alkoxy
oxa
Prior art date
Application number
SG96294A
Other languages
English (en)
Inventor
Edit Toth
Jozsef Torley
Laszlo Dr Szporny
Bela Kiss
Egon Dr Karpati
Eva Dr Palosi
Dora Dr Groo
Istvan Dr Laszlovszky
Zsolt Dr Szombathelyi
Adam Dr Sarkadi
Aniko Gere
Katalin Csomor
Mihaly Dr Bodo
Judit Dr Laszy
Zsolt Szentirmay
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to HU894095A priority Critical patent/HU204530B/hu
Priority to IL9532090A priority patent/IL95320A/en
Priority to AU60807/90A priority patent/AU622039B2/en
Priority to ES90308784T priority patent/ES2052180T3/es
Priority to DE69007904T priority patent/DE69007904T2/de
Priority to DK90308784.9T priority patent/DK0414421T3/da
Priority to NZ234848A priority patent/NZ234848A/en
Priority to DD90343361A priority patent/DD299429A5/de
Priority to ZA906302A priority patent/ZA906302B/xx
Priority to EP90308784A priority patent/EP0414421B1/fr
Priority to JP2209358A priority patent/JPH0749431B2/ja
Priority to SI9011538A priority patent/SI9011538A/sl
Priority to AT90308784T priority patent/ATE103920T1/de
Priority to IE288490A priority patent/IE64911B1/en
Priority to KR1019900012256A priority patent/KR940006635B1/ko
Priority to NO903512A priority patent/NO177962C/no
Priority to FI903972A priority patent/FI93455C/fi
Priority to PL90286440A priority patent/PL163370B1/pl
Priority to PL90291702A priority patent/PL163593B1/pl
Priority to PL90291701A priority patent/PL163431B1/pl
Priority to US07/566,275 priority patent/US5118687A/en
Priority to HRP-1538/90A priority patent/HRP920778A2/hr
Priority to BG098261A priority patent/BG60436B2/bg
Priority to SG96294A priority patent/SG96294G/en
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Priority to HU94P/P00036P priority patent/HU210072A9/hu
Publication of SG96294G publication Critical patent/SG96294G/en
Priority to HK145994A priority patent/HK145994A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
SG96294A 1989-08-10 1994-07-16 1-oxa-2-oxo-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof SG96294G (en)

Priority Applications (26)

Application Number Priority Date Filing Date Title
HU894095A HU204530B (en) 1989-08-10 1989-08-10 Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
NO903512A NO177962C (no) 1989-08-10 1990-08-09 Analogifremgangsmåte for fremstilling av terapeutisk aktive 1-oxa-2-oxo-8-azaspiro[4,5Ådecan-derivater
IE288490A IE64911B1 (en) 1989-08-10 1990-08-09 1-oxa-2-oxo-8-azaspiro[4,5] decane derivatives processes for their preparation and pharmaceutical compositions thereof
DE69007904T DE69007904T2 (de) 1989-08-10 1990-08-09 1-Oxa-2-oxo-8-azaspiro[4,5]decan-Derivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen daraus.
DK90308784.9T DK0414421T3 (da) 1989-08-10 1990-08-09 1-Oxa-2-oxo-8-azaspiro(4,5)decan-derivater, fremgangsmåder til deres fremstilling samt farmaceutiske præparater med indhold deraf
NZ234848A NZ234848A (en) 1989-08-10 1990-08-09 1-oxa-2-oxo-3-(oxa or aza)-8-azaspiro(4,5)decane derivatives and pharmaceutical compositions
DD90343361A DD299429A5 (de) 1989-08-10 1990-08-09 Neue 1-oxa-2-oxo-8-aza-spiro[4,5]dekan-derivate und verfahren zur herstellung dieser verbindungen
AU60807/90A AU622039B2 (en) 1989-08-10 1990-08-09 Novel 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives, pharmaceutical compositions containing them and process for preparing the same
EP90308784A EP0414421B1 (fr) 1989-08-10 1990-08-09 Dérivés de 1-oxa-2-oxo-8-azaspiro[4,5]décane, procédés pour leur préparation et compositions pharmaceutiques à partir de ceux-ci
JP2209358A JPH0749431B2 (ja) 1989-08-10 1990-08-09 １―オキサ―２―オキソ―アザスピロ〔４，５〕デカン誘導体
SI9011538A SI9011538A (sl) 1989-08-10 1990-08-09 Novi 1-oksa-2-okso-8-azaspiro/4,5/dekanski derivati, farmacevtski pripravki, ki jih vsebujejo, in postopek za njihovo pripravo
AT90308784T ATE103920T1 (de) 1989-08-10 1990-08-09 1-oxa-2-oxo-8-azaspiro(4,5>decan-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen daraus.
ES90308784T ES2052180T3 (es) 1989-08-10 1990-08-09 Derivados de 1-oxa-2-oxo-8-azaespiro(4,5)decano, procesos para su preparacion y composiciones farmaceuticas de los mismos.
IL9532090A IL95320A (en) 1989-08-10 1990-08-09 4-Transformed History of 8-Phenylalkyl-1-Oxa-2 Oxo-8-Azaspiri [4,5] Decan, Preparation and Pharmaceutical Preparations Containing Them
KR1019900012256A KR940006635B1 (ko) 1989-08-10 1990-08-09 1-옥사-2-옥소-8-아자스피로[4,5]데칸 유도체와 그들을 포함하는 약제학적 조성물 및 그 제조방법
ZA906302A ZA906302B (en) 1989-08-10 1990-08-09 Novel 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives,pharmaceutical compositions containing them and process for preparing same
PL90286440A PL163370B1 (pl) 1989-08-10 1990-08-10 Sposób wytwarzania nowych pochodnych 1-oksa-2-okso-8-azaspiro-[4. 5] dekanu PL PL
PL90291702A PL163593B1 (en) 1989-08-10 1990-08-10 Method of obtaining novel derivatives of 1-oxa-2-oxo-8-azaspiro [4,5] decane
PL90291701A PL163431B1 (pl) 1989-08-10 1990-08-10 Sposób wytwarzania nowych pochodnych 1-oksa-2-okso-8-azaspiro[4.5]dekanu PL PL
FI903972A FI93455C (fi) 1989-08-10 1990-08-10 Menetelmä uusien terapeuttisesti käyttökelpoisten 1-oksa-2-okso-8-atsaspiro/4,5/dekaanijohdannaisten valmistamiseksi
US07/566,275 US5118687A (en) 1989-08-10 1990-08-10 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives, pharmaceutical compositions containing them and process for preparing same
HRP-1538/90A HRP920778A2 (en) 1989-08-10 1992-10-01 Novel 1-oxa-2-oxo-8-azaspiro74,5/ decane derivatives, pharmaceutical preparations containing them and process for the preparation thereof
BG098261A BG60436B2 (bg) 1989-08-10 1993-12-02 1-окса-2-оксо-8-азаспиро(4,5)декани,фармацевтични състави, които ги съдържат,и метод за получаването им
SG96294A SG96294G (en) 1989-08-10 1994-07-16 1-oxa-2-oxo-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof
HU94P/P00036P HU210072A9 (en) 1989-08-10 1994-10-12 Novel 1-oxa-2-oxo-8-azaspiro/4,5/decane derivatives, pharmaceutical compositions containing them and process for preparing same
HK145994A HK145994A (en) 1989-08-10 1994-12-22 1-Oxa-2-oxo-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU894095A HU204530B (en) 1989-08-10 1989-08-10 Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them
SG96294A SG96294G (en) 1989-08-10 1994-07-16 1-oxa-2-oxo-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof

Publications (1)

Publication Number Publication Date
SG96294G true SG96294G (en) 1994-10-28

Family

ID=26317733

Family Applications (1)

Application Number Title Priority Date Filing Date
SG96294A SG96294G (en) 1989-08-10 1994-07-16 1-oxa-2-oxo-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof

Country Status (23)

Country Link
US (1) US5118687A (fr)
EP (1) EP0414421B1 (fr)
JP (1) JPH0749431B2 (fr)
KR (1) KR940006635B1 (fr)
AT (1) ATE103920T1 (fr)
AU (1) AU622039B2 (fr)
BG (1) BG60436B2 (fr)
DD (1) DD299429A5 (fr)
DE (1) DE69007904T2 (fr)
DK (1) DK0414421T3 (fr)
ES (1) ES2052180T3 (fr)
FI (1) FI93455C (fr)
HK (1) HK145994A (fr)
HR (1) HRP920778A2 (fr)
HU (2) HU204530B (fr)
IE (1) IE64911B1 (fr)
IL (1) IL95320A (fr)
NO (1) NO177962C (fr)
NZ (1) NZ234848A (fr)
PL (3) PL163593B1 (fr)
SG (1) SG96294G (fr)
SI (1) SI9011538A (fr)
ZA (1) ZA906302B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU150489A (sh) * 1989-08-10 1992-12-21 W.L. Gore & Co. Gmbh. Uređaj za ispitivanje odevnih predmeta na nepromočivost
PT1223990E (pt) * 1999-10-15 2004-12-31 Fidia Advanced Biopolymers Srl Formulacoes de acido hialuronico para administracao de proteinas osteogenicas
KR20020091462A (ko) * 2001-05-30 2002-12-06 삼성광주전자 주식회사 원료 굳음 방지기능을 갖는 자동판매기 및 그 제어방법
GB201416346D0 (en) * 2014-09-16 2014-10-29 Shire Internat Gmbh Spirocyclic derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR96352E (fr) * 1967-12-29 1972-06-16 Science Union & Cie Nouveaux dérives du spiro (4,5) decane et leur procédé de préparation.
BE790675A (fr) * 1971-10-29 1973-04-27 Science Union & Cie Nouveaux derives de l'oxa-1 diaza-3,8 spiro (4,5) decane
EP0189370A3 (fr) * 1985-01-16 1988-01-27 Sandoz Ag Spiro-dioxolanes, -dithiolanes et -oxothiolanes
KR940003491B1 (ko) * 1989-08-10 1994-04-23 리히터 게데온 베기에스제티 기아르 알.티 4,4-이중 치환된 피페리딘 유도체와 그 제조방법 및 상기 화합물을 함유하는 약제학적 조성물
HU204529B (en) * 1989-08-10 1992-01-28 Richter Gedeon Vegyeszet Process for producing new 1-oxa-2-oxo-8-aza-spiro(4,5)decane derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
DE69007904T2 (de) 1994-07-21
HUT55786A (en) 1991-06-28
FI93455B (fi) 1994-12-30
KR910004632A (ko) 1991-03-29
PL163431B1 (pl) 1994-03-31
EP0414421B1 (fr) 1994-04-06
PL291702A1 (en) 1992-05-04
DK0414421T3 (da) 1994-05-16
NO903512L (no) 1991-02-11
KR940006635B1 (ko) 1994-07-23
DD299429A5 (de) 1992-04-16
AU6080790A (en) 1991-02-14
JPH0749431B2 (ja) 1995-05-31
EP0414421A3 (en) 1991-07-24
SI9011538A (sl) 1998-08-31
EP0414421A2 (fr) 1991-02-27
PL291701A1 (en) 1992-05-04
NO903512D0 (no) 1990-08-09
NZ234848A (en) 1992-03-26
ATE103920T1 (de) 1994-04-15
IL95320A (en) 1994-01-25
NO177962C (no) 1995-12-27
JPH0377884A (ja) 1991-04-03
BG60436B2 (bg) 1995-03-31
IE902884A1 (en) 1991-02-27
FI93455C (fi) 1995-04-10
PL163370B1 (pl) 1994-03-31
HU204530B (en) 1992-01-28
US5118687A (en) 1992-06-02
ES2052180T3 (es) 1994-07-01
AU622039B2 (en) 1992-03-26
NO177962B (no) 1995-09-18
FI903972A0 (fi) 1990-08-10
HRP920778A2 (en) 1998-02-28
HU210072A9 (en) 1995-02-28
PL163593B1 (en) 1994-04-29
HK145994A (en) 1994-12-30
ZA906302B (en) 1991-06-26
PL286440A1 (en) 1992-01-27
IL95320A0 (en) 1991-06-30
IE64911B1 (en) 1995-09-20
DE69007904D1 (de) 1994-05-11

Similar Documents

Publication Publication Date Title
IL95321A0 (en) 2-oxo-1-oxa-8-azaspiro(4,5)decane derivatives,their preparation and pharmaceutical compositions containing them
ES2040856T3 (es) Un procedimiento para preparar un compuesto de tiofeno.
HK145994A (en) 1-Oxa-2-oxo-8-azaspiro[4,5] decane derivatives, processes for their preparation and pharmaceutical compositions thereof
HUT58269A (en) Process for producing aralkyl-amine derivatives and pharmaceutical compositions containing them as active components
FI903973A0 (fi) Nya 2-oxo-1-oxa-8-azaspiro/4,5/ dekanderivat, farmaceutiska kompositioner innehaollande dessa och foerfarande foer framstaellning av dessa.
FI903511A0 (fi) Pyrrolo (2,1-b) tiazolderivat.